BioDelivery Sciences International, Inc.(BDSI): For the most recent quarter end, BioDelivery Sciences International, Inc. reported Annual Earnings of $-0.3. Based on the filings, last years Annual Earnings was, $-0.72. For the most recent quarter end, BDSI reported a surprise Earnings per Share of -15.38% . The consensus estimate for current quarter is $-0.27 and for the current fiscal year, the estimate is $-1.24. For the Next fiscal year, the estimate is $-0.7 based on the consensus.
BioDelivery Sciences International, Inc. has received $-0.27 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 5 Financial Advisor in the Stock Trading Firms. Among 5 Analysts, Bottom line EPS Estimate for the current quarter is $-0.3 while the top line estimate is $-0.25 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at -236%. BioDelivery Sciences International, Inc. results fell short with a surprise EPS of -15.38% or $-0.04. The Actual EPS was $-0.3 compared to the Estimated EPS of $-0.26 during its most recent quarterly earnings.
BioDelivery Sciences International Last issued its quarterly earnings results on Nov 9, 2016. The company reported $-0.30 EPS for the quarter, missing the analyst consensus estimate by $ -0.04. Analyst had a consensus of $-0.26. The company had revenue of $3.60 million for the quarter, compared to analysts expectations of $3.61 million. The companys revenue was up 200.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.39 EPS.
Company has reported several Insider transactions to the SEC, on Feb 8, 2017, Niraj Vasisht (officer ) sold 6,905 shares at 1.91 per share price.On Dec 2, 2016, Samuel P Jr Sears (director) sold 12,000 shares at 1.67 per share price.On Nov 25, 2016, Barry I Feinberg (director) purchased 2,000 shares at 1.62 per share price.
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) rose 7.89% or 0.15 points on Wednesday and made its way into the gainers of the day. After trading began at $1.9 the stock was seen hitting $2.06 as a peak level and $1.875 as the lowest level. The stock ended up at $2.05. The daily volume was measured at 916,457 shares. The 52-week high of the share price is $4.39 and the 52-week low is $1.5. The company has a market cap of $111 million.
BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any process, substance, or combination thereof, that delivers drugs into the body.